
Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases
Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases
- 1st Edition - January 10, 2024
- Imprint: Academic Press
- Editors: Tapan Behl, Sukhbir Singh, Neelam Sharma
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 5 8 7 - 3
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 5 8 8 - 0
Targeting Angiogenesis, Inflammation and Oxidative Stress in Chronic Diseases presents recent advances in the vivid molecular pathways targeting angiogenesis, inflammation, and ox… Read more
Purchase options

Institutional subscription on ScienceDirect
Request a sales quote- Focuses on the pathogenesis of the disease, along with the molecular mechanism of action
- Includes updates on strategic design/delivery of drugs targeting angiogenesis, inflammation, and oxidative stress
- Provides recent advancements in the field of pathogenesis of chronic diseases
2. Targeting angiogenesis, inflammation, and oxidative stress in obesity
3. Molecular role of angiogenesis, inflammation and oxidative stress in cancer
4. Rheumatoid arthritis: Its etiology, pathophysiology, and treatment
5. Inflammatory bowel diseases (IBDs)
6. Natural and synthetic agents targeting angiogenesis, oxidative stress, and inflammation in psoriasis
7. Unveiling the pharmacological and nanotechnological aspects for the management of hypertension: State-of-the-art and future perspectives
8. Decrypting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of congestive heart failure: Nanotechnology as a boon for the management of congestive heart failure
9. Expatiating the role of angiogenesis, inflammation and oxidative stress in angina pectoris: A state-of-the-art on the drug delivery approaches
10. Targeting angiogenesis, inflammation, and oxidative stress in Alzheimer’s siseases
11. Advancement in herbal drugs for the treatment of Parkinson’s disease
12. Targeting angiogenesis, inflammation, and oxidative stress in depression
13. Role of inflammation, angiogenesis and oxidative stress in developing epilepsy
14. Diabetic retinopathy: Stressing the function of angiogenesis, inflammation and oxidative stress in the disease
15. Targeting the role of angiogenesis, inflammation and oxidative stress in pathogenesis of glaucoma: Strategic nanotechnology based drug delivery approaches
16. Age-associated macular degeneration: Epidemiologic features, complications, and potential therapeutic approaches
17. Intricate the potential role of nanotechnology as cutting-edge for management of hirsutism and gynecosmatia: A paradigm in therapeutics
18. Role of angiogenesis, inflammation and oxidative stress in polycystic ovary syndrome (PCOS): Current perspectives
- Edition: 1
- Published: January 10, 2024
- No. of pages (Paperback): 522
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9780443135873
- eBook ISBN: 9780443135880
TB
Tapan Behl
Professor Tapan Behl is based at Amity School of Pharmaceutical Sciences, Amity University, Sahibzada Ajit Singh Nagar, Punjab, India. Dr. Tapan Behl completed his doctoral studies from Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India and thereafter worked as Post-Doctoral Researcher. His areas of interest include diabetes and associated complications, molecular pharmacology and neuropathic pain and its complications. Dr. Behl has published more than 400 research and review papers in International and National journals. He has also published International books and is continuously engaged in exploring the molecular mechanisms in diabetes and related complications, rheumatoid arthritis and obesity.
SS
Sukhbir Singh
Professor Sukhbir Singh has a PhD in Pharmaceutical Science and experience of more than 15 years in academia and research. He has 170 publications in various National/International journal of repute, 8 books, 12 books chapter and filed 19 patents to his credit. He has presented/published 40 review/research abstracts in various National/International conferences. His areas of interest in research are nanotechnology/liposome/niosomes/SEDDS based formulation development and solubility enhancement of BCS class II drugs. He has expertise in operation of various statistical analysis tools
NS